[{"Assets_0_Q3_USD":286721000.0,"CommonStockSharesOutstanding_0_Q3_shares":44453724.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-35889000.0,"NetIncomeLoss_1_Q3_USD":-10812000.0,"NetIncomeLoss_3_Q3_USD":-37299000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":44452184.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":33937800.0,"StockholdersEquity_0_Q3_USD":245121000.0,"Ticker":"RCUS","CIK":"1724521","name":"ARCUS BIOSCIENCES, INC.","OfficialName":"Arcus Biosciences Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2226368293.0","Country":"nan","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20181108"}]